PAUL HOPKINS to Mutation
This is a "connection" page, showing publications PAUL HOPKINS has written about Mutation.
Connection Strength
0.268
-
Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. J Lipid Res. 1999 Jun; 40(6):1113-22.
Score: 0.058
-
A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia. J Hum Genet. 1999; 44(6):364-7.
Score: 0.056
-
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia. J Clin Lipidol. 2018 Mar - Apr; 12(2):390-396.e8.
Score: 0.052
-
Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening. Curr Opin Lipidol. 2017 Apr; 28(2):136-143.
Score: 0.050
-
Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Curr Atheroscler Rep. 2007 Sep; 9(3):179-86.
Score: 0.026
-
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia. J Clin Lipidol. 2017 Nov - Dec; 11(6):1338-1346.e7.
Score: 0.013
-
The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach. Metabolism. 2011 Aug; 60(8):1150-7.
Score: 0.008
-
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides. Clin Genet. 2001 Feb; 59(2):88-98.
Score: 0.004
-
Clinical application of deoxyribonucleic acid markers in a Utah family with hypercholesterolemia. Am J Cardiol. 1989 Jan 01; 63(1):109-12.
Score: 0.002